Cover Image
市場調查報告書

B型肝炎及C型肝炎診斷的全球市場:2016∼2020年

Global Hepatitis B and C Diagnostics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 369180
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
Back to Top
B型肝炎及C型肝炎診斷的全球市場:2016∼2020年 Global Hepatitis B and C Diagnostics Market 2016-2020
出版日期: 2016年08月30日 內容資訊: 英文 110 Pages
簡介

B型肝炎的診斷中有HBV血清檢驗,分子去氧核糖核酸檢驗,組織學檢驗,C型肝炎的診斷有HCV血清檢驗,HCV重組的免疫印跡法抗體檢驗,分子核糖核酸檢驗等。全球B型肝炎及C型肝炎診斷市場預計2016∼2020年以6.35%的年複合成長率擴大

本報告提供全球B型肝炎及C型肝炎診斷市場相關調查,各市場手藝,各疾病,各地區趨勢,今後的成長預測,以及加入此市場的主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 償付方案:概要

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 B型肝炎及C型肝炎診斷的全球市場:各手藝市場區隔

  • 免疫診斷
  • 免疫螢光法
  • 設備
  • 試劑
  • NAT

第8章 B型肝炎及C型肝炎診斷的全球市場:各疾病市場區隔

  • B型肝炎
  • C型肝炎

第9章 B型肝炎及C型肝炎診斷的全球市場:各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 B型肝炎及C型肝炎診斷的全球市場:促進要素

  • 分子診斷的需求擴大
  • 診斷流程簡略化的醫療機關的策略
  • POC診斷的需求擴大
  • 自動化和系統整合的需求擴大

第11章 促進要素的影響

第12章 B型肝炎及C型肝炎診斷的全球市場:課題

  • 未診斷人口很多
  • 有限的檢測能力和化驗的複雜度
  • 法律規章和償付門檻限制引進率
  • 封閉系統的限制

第13章 促進要素與課題的影響

第14章 B型肝炎及C型肝炎診斷的全球市場:趨勢

第15章 供應商環境

  • 競爭模式
  • 主要消息

第16章 主要供應商

  • Abbott Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare
  • QIAGEN
  • 其他值得注意的供應商

第17章 附錄

第18章 關於Technavio

目錄
Product Code: IRTNTR10208

About Hepatitis B and Hepatitis C

Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.

Technavio's analysts forecast the global hepatitis B and C diagnostics market to grow at a CAGR of 6.35% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global hepatitis B and C diagnostics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of immunodiagnostics and nucleic acid test (NAT) instruments and consumables to hospitals, diagnostic centers, and research institutes.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Hepatitis B and C Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare
  • QIAGEN

Other Prominent Vendors

  • Affymetrix
  • Allele Biotechnology
  • Axis-Shield
  • Becton Dickinson
  • bioMerieux
  • Cepheid
  • Chembio Diagnostics
  • DiaMetra
  • DiaSorin
  • Enzo Life Sciences
  • Hologic
  • ImmunoDX
  • MedMira
  • OraSure Technologies
  • Quest Diagnostics
  • Quidel
  • Randox Laboratories
  • Vela Diagnostics
  • Vital Diagnostics
  • ZEUS Scientific

Market driver

  • Strategies of healthcare organizations toward simplifying the diagnostic process
  • For a full, detailed list, view our report

Market challenge

  • Regulatory and reimbursement hurdles limit the adoption rate
  • For a full, detailed list, view our report

Market trend

  • Advent of immunosensors in the HBV and HCV diagnostic tests
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Hepatitis B and C diagnostics: An overview
  • Hepatitis B disease overview
  • Hepatitis C disease overview

PART 05: Reimbursement scenario: An overview

PART 06: Market landscape

  • Market overview
  • Global hepatitis B and C diagnostics market overview
  • Five forces analysis

PART 07: Market segmentation by procedure

  • Immunodiagnostics
  • Immunofluorescence
  • Instruments
  • Reagents
  • Global hepatitis B and C immunodiagnostics market overview
  • NAT
  • Global hepatitis B and C NAT market overview

PART 08: Market segmentation by disease

  • Hepatitis B
  • Global hepatitis B diagnostics market overview
  • Hepatitis C
  • Global hepatitis C diagnostics market overview

PART 09: Geographical segmentation

  • Hepatitis B and C diagnostics market in Americas
  • Hepatitis B and C diagnostics market in EMEA
  • Hepatitis B and C diagnostics market in APAC

PART 10: Market drivers

  • Growing demand for molecular diagnostics in the diagnosis of HBV and HCV
  • Strategies of healthcare organizations toward simplifying the diagnostic process
  • Rising demand for POC diagnostics
  • Increase in demand for automation and system integration

PART 11: Impact of drivers

PART 12: Market challenges

  • Presence of high undiagnosed individuals
  • Limited detection capability and complexity of assays
  • Regulatory and reimbursement hurdles limit the adoption rate
  • Limitations of closed systems

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Advent of immunosensors in the HBV and HCV diagnostic tests
  • Paradigm shift toward the use of hepatitis C core antigen test
  • High demand for biomarker-based tests

PART 15: Vendor landscape

  • Competitive scenario
  • Key news

PART 16: Key vendor analysis

  • Abbott Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare
  • QIAGEN
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Possible outcomes of HBV infection
  • Exhibit 03: Concentration of HBV in several body fluids
  • Exhibit 04: Pathway of hepatitis B progression
  • Exhibit 05: Disease progression of hepatitis B
  • Exhibit 06: Significance of serological markers
  • Exhibit 07: Types of hepatitis B diagnostic tests
  • Exhibit 08: Diagnostic strategies for HBV
  • Exhibit 09: Interpretation of serological markers
  • Exhibit 10: Endemicity pattern of hepatitis B across different regions
  • Exhibit 11: Medical cost for chronic viral hepatitis
  • Exhibit 12: Progression of hepatitis C
  • Exhibit 13: Risk factors for hepatitis transmission
  • Exhibit 14: Screening tests for hepatitis C infection
  • Exhibit 15: Medical cost for hepatitis C and related infections
  • Exhibit 16: Reimbursement perspectives of healthcare entities
  • Exhibit 17: Global hepatitis B and C diagnostics market analysis: Developed and emerging markets
  • Exhibit 18: Snapshot of global hepatitis B and C diagnostics market
  • Exhibit 19: Global hepatitis B and C diagnostics market 2025-2020 ($ billions)
  • Exhibit 20: Opportunity analysis of hepatitis B and C diagnostics market
  • Exhibit 21: Five forces analysis
  • Exhibit 22: Global hepatitis B and C diagnostics market by procedure 2015-2020
  • Exhibit 23: Global hepatitis B and C diagnostics market by procedure 2015 ($ billions)
  • Exhibit 24: Global hepatitis B and C diagnostics market by procedure: Lifecycle analysis 2015
  • Exhibit 25: Global hepatitis B and C immunodiagnostics market 2025-2020 ($ billions)
  • Exhibit 26: Opportunity analysis of immunodiagnostics
  • Exhibit 27: Global hepatitis B and C immunodiagnostics market segmentation by product type 2015
  • Exhibit 28: Global hepatitis B and C NAT market 2025-2020 ($ millions)
  • Exhibit 29: Global hepatitis B and C NAT market segmentation by product type 2015
  • Exhibit 30: Opportunity analysis of global hepatitis B and C NAT market
  • Exhibit 31: Global hepatitis B and C diagnostics market segmentation by procedure 2025-2020 ($ millions)
  • Exhibit 32: Global hepatitis B and C diagnostics market segmentation by procedure 2025-2020 (%)
  • Exhibit 33: Global hepatitis B and C diagnostics market segmentation: Impact analysis 2015-2020
  • Exhibit 34: Global hepatitis B and C diagnostics market by disease type 2015-2020
  • Exhibit 35: Global hepatitis B and C diagnostics market by disease type 2015
  • Exhibit 36: Global hepatitis B and C diagnostics market by disease type: Lifecycle analysis 2015
  • Exhibit 37: Acute hepatitis B infection by demography 2015
  • Exhibit 38: Chronic hepatitis B infection by demography 2015
  • Exhibit 39: Procurement of hepatitis B diagnostic kits by WHO 2015
  • Exhibit 40: Global hepatitis B diagnostics market 2015-2020 ($ millions)
  • Exhibit 41: Opportunity analysis of global hepatitis B diagnostics market
  • Exhibit 42: Prevalence rates of hepatitis C across different regions 2015
  • Exhibit 43: Treatment cost of hepatitis C-related infections
  • Exhibit 44: Procurement of hepatitis C diagnostic kits by WHO 2015
  • Exhibit 45: Opportunity analysis of hepatitis C
  • Exhibit 46: Global hepatitis C diagnostics market 2015-2020 ($ billions)
  • Exhibit 47: Global hepatitis B and C diagnostics market by disease type 2015-2020 ($ millions)
  • Exhibit 48: Global hepatitis B and C diagnostics market by disease type 2015-2020 (%)
  • Exhibit 49: Global hepatitis B and C diagnostics segmentation by disease type
  • Exhibit 51: Geographical hepatitis B and C diagnostics market 2015
  • Exhibit 52: Global hepatitis B and C diagnostics: Regional market lifecycle analysis
  • Exhibit 53: Global hepatitis B and C diagnostics market by geography 2015-2020
  • Exhibit 54: Global hepatitis and C diagnostics market segmentation by geography 2015
  • Exhibit 55: Global hepatitis B and C diagnostics market by geography lifecycle analysis 2015
  • Exhibit 56: Hepatitis B and C diagnostics in Americas 2015
  • Exhibit 57: Prevalence data of hepatitis C in North America
  • Exhibit 58: Prevalence data of hepatitis C in Latin America
  • Exhibit 59: Hepatitis B and C diagnostics market in Americas 2015-2020 ($ billions)
  • Exhibit 60: Prevalence data of hepatitis C in Europe
  • Exhibit 61: Hepatitis B and C diagnostics market in EMEA 2015-2020 ($ billions)
  • Exhibit 62: Prevalence rate of hepatitis B in APAC
  • Exhibit 63: Prevalence data of hepatitis C in APAC
  • Exhibit 64: Hepatitis B and C diagnostics market in EMEA 2015-2020 ($ billions)
  • Exhibit 65: Global hepatitis B and C diagnostics market by geography 2025-2020 ($ millions)
  • Exhibit 66: Global hepatitis B and C diagnostics market by geography 2025-2020 (%)
  • Exhibit 67: Global hepatitis B and C diagnostics market by geography
  • Exhibit 68: Strategies of healthcare organizations
  • Exhibit 69: Advantages of POC diagnostics
  • Exhibit 70: Recent and expected product launches of HCV POC diagnostic tests
  • Exhibit 71: Impact of drivers
  • Exhibit 72: Prevalence and diagnosis of HCV infections across developing countries 2015 (millions)
  • Exhibit 73: Key factors affecting the adoption rates
  • Exhibit 74: Force field analysis of global hepatitis b and C diagnostics market
  • Exhibit 75: Impact of drivers and challenges
  • Exhibit 76: Key advantages driving the adoption of HCV core antigen test
  • Exhibit 77: Impact of trends on global hepatitis B and C diagnostics market 2015-2020
  • Exhibit 78: Key leading vendors ranking for instruments 2015
  • Exhibit 79: Presence of vendors in the global hepatitis B and C diagnostics market
  • Exhibit 80: Abbott Laboratories: Key business offerings
  • Exhibit 81: Abbott Diagnostics: Metric analysis
  • Exhibit 82: Hoffmann-La Roche: Business segmentation by revenue 2015
  • Exhibit 83: Roche Diagnostics: Products and description
  • Exhibit 84: Roche Diagnostics: Business segmentation by revenue 2015
  • Exhibit 85: Roche Diagnostics: Metric analysis
  • Exhibit 86: Siemens Healthcare: Various tests available in multiple diseases
  • Exhibit 87: Siemens Healthcare: Metric analysis
  • Exhibit 88: QIAGEN: Metric analysis
Back to Top